StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.63−0.84 (-2.97%)

Close on Nov 19, 2026Market cap $3.41BP/E –Yield –

Parabilis Medicines shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Parabilis Medicines's shares outstanding was 29M at Jun 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202629M–
Q2 FY2025Jun 30, 20252M–

More Parabilis Medicines figures

See a number that looks wrong?